Clinical trial
Mercury Levels in Premature and LBW Infants Receiving Thimerosal-containing…
NCT00138333 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00138333 |
|---|---|
| Title | Mercury Levels in Premature and LBW Infants Receiving Thimerosal-containing Vaccines |
| Official title | Assessment of Mercury Levels and Metabolism in Premature and Low Birth Weight (LBW) Infants Receiving Vaccines Containing Thimerosal |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Mercury Levels |
| Enrollment | 71 |
| Start date | Dec 1, 2005 |
| Completion | Nov 1, 2006 |
| First posted | Aug 30, 2005 |
| Last update posted | Nov 11, 2011 |
| Countries | Argentina |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: